Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke

Table 5

Effect of resveratrol on glucose.

Evaluation	Glucose (mg/dL)
	Diabetics	ES	Nondiabetics	ES
Resveratrol 100 mg group
Initial	142.18 ± 15.22	—	96.67 ± 11.26	—
At 6 months	136.29 ± 14.48	0.39	91.23 ± 10.75	0.48
At 12 months	134.24 ± 14.31	0.14	87.12 ± 10.61	0.38
Resveratrol 200 mg group
Initial	142.46 ± 15.24	—	96.98 ± 11.23	—
At 6 months	136.21 ± 14.56	0.41	91.21 ± 10.67	0.51
At 12 months	133.89 ± 15.68	0.16	86.11 ± 10.78	0.48
Control group
Initial	142.47 ± 15.83	—	95.71 ± 11.63	—
At 6 months	141.81 ± 15.31	0.04	94.55 ± 11.22	0.10
At 12 months	140.58 ± 15.62	0.08	93.33 ± 11.28	0.11

Values are represented as mean ± SD ( diabetic and nondiabetic patients in the resveratrol 100 mg group; diabetic and nondiabetic patients in the resveratrol 200 mg group; and diabetic and nondiabetic patients in the control group); versus initial value; <0.05 versus control group value.